Chatham Capital Group, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Chatham Capital Group, Inc.
- $649 Million
- Q4 2025
A detailed history of Chatham Capital Group, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 3,153 shares of XBI stock, worth $359,473. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,153
Previous 4,413
28.55%
Holding current value
$359,473
Previous $442,000
18.78%
% of portfolio
0.06%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding XBI
# of Institutions
857Shares Held
121MCall Options Held
28.4MPut Options Held
34.2M-
Goldman Sachs Group Inc New York, NY22.7MShares$2.59 Billion0.29% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613.8MShares$1.58 Billion2.64% of portfolio
-
Jpmorgan Chase & CO New York, NY13.5MShares$1.54 Billion0.09% of portfolio
-
Citigroup Inc10.9MShares$1.24 Billion0.5% of portfolio
-
Morgan Stanley New York, NY10.6MShares$1.21 Billion0.07% of portfolio